Caribou Gets FDA Fast-Track Designation for CB-011 in Multiple Myeloma

By Colin Kellaher


Caribou Biosciences Inc. on Tuesday said the U.S. Food and Drug Administration granted fast-track designation to CB-011, in development for relapsed or refractory multiple... | April 4, 2023

Related Keywords

Berkeley ,California ,United States ,Colin Kellaher ,Drug Administration ,Caribou Biosciences Inc ,Dow Jones ,Caribou Biosciences ,Nc Stock Exchange ,News ,Information ,Press Release ,Y ,Colin ,Kellaher ,Caribou ,Iosciences ,N ,Tuesday ,Aid ,The ,Wood ,End ,Drug ,Administration ,Granted ,Resignation ,O ,Development ,Or ,Relapsed ,Dr ,Efractory Crbu Us1420381089 ,